0002156481-26-000001.txt : 20261001 0002156481-26-000001.hdr.sgml : 20261001 20261001152925 ACCESSION NUMBER: 0002156481-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261001 DATE AS OF CHANGE: 20261001 EFFECTIVENESS DATE: 20261001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solaris Endovascular Inc. CENTRAL INDEX KEY: 0002156481 ORGANIZATION NAME: EIN: 994266524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-599654 FILM NUMBER: 261431009 BUSINESS ADDRESS: STREET 1: 3232 MCKINNEY AVENUE STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75204 BUSINESS PHONE: 215-688-6196 MAIL ADDRESS: STREET 1: 3232 MCKINNEY AVENUE STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75204 D 1 primary_doc.xml X0708 D LIVE 0002156481 Solaris Endovascular Inc. 3232 MCKINNEY AVENUE SUITE 500 DALLAS TX TEXAS 75204 215-688-6196 DELAWARE None None Corporation true 2024 Randolph W. Hubbell 3232 McKinney Avenue Suite 500 Dallas TX TEXAS 75204 Executive Officer Director Alexander Marra Moreira 3232 McKinney Avenue Suite 500 Dallas TX TEXAS 75204 Director Melchiades de Cunha Neto 3232 McKinney Avenue Suite 500 Dallas TX TEXAS 75204 Director Marco Costa 3232 McKinney Avenue Suite 500 Dallas TX TEXAS 75204 Director David Stack 3232 McKinney Avenue Suite 500 Dallas TX TEXAS 75204 Director Matthew Head 3232 McKinney Avenue Suite 500 Dallas TX TEXAS 75204 Executive Officer Biotechnology Decline to Disclose 06b false 2025-09-05 false true true true false 2500 10000000 4972500 5027500 false 45 0 0 0 false Solaris Endovascular Inc. /s/ Giles D. Beal IV Giles D. Beal IV by POA from Randolph W. Hubbell, Chief Executive Officer 2026-10-01